[CRVS] YoY Quarter Result on 31-Dec-2018 [#Q4]

Stock
[CRVS] Corvus Pharmaceuticals, Inc.
Announcement Date
07-Mar-2019
Financial Year
2018
Quarter
31-Dec-2018 [#Q4]
Profit Trend
QoQ- -0.10%
YoY- 11.90%
Quarter Report
CRVS's Result
CRVS's Financial Summary
View:
Show?
Quarter Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -9,236 27,347 -11,047 -10,509 -11,929 -11,086 -6,039 7.33%
Tax 8 -143 -185 -180 -219 -184 17,600 -72.23%
NP -9,236 27,347 -11,047 -10,509 -11,929 -11,086 -6,039 7.33%
Tax Rate - 0.52% - - - - - -
Total Cost 9,236 -27,347 11,047 10,509 11,929 11,086 6,039 7.33%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS -0.20 0.92 -0.38 -0.36 -0.58 -0.55 -0.68 -18.43%
EPS Diluted -0.20 0.92 -0.38 -0.36 -0.58 -0.55 -0.68 -18.43%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.